يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"KRAS mutation G12C"', وقت الاستعلام: 0.35s تنقيح النتائج
  1. 1
    Academic Journal
    Assessment of KRASG12C inhibitors for colorectal cancer

    المؤلفون: Gary A. Piazza, Preethi Chandrasekaran, Yulia Y. Maxuitenko, Karim I. Budhwani

    المصدر: Frontiers in Oncology, Vol 14 (2024)

    مصطلحات موضوعية: colorectal cancer, KRAS G12C inhibitors, resistance, clinical trials, KRAS mutation G12C, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1412435/full; https://doaj.org/toc/2234-943X

    URL الوصول: https://doaj.org/article/b8b756094a9d42089d0c4751ec0c101a

    View record in DOAJ Full Text Finder

    أضف إلى المفضلة
  2. 2
    Academic Journal
    Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway

    المؤلفون: Frontiers Editorial Office

    المصدر: Frontiers in Oncology, Vol 11 (2021)

    مصطلحات موضوعية: KRAS mutation G12C, inhibitor 9, castration-resistant prostate cancer, drug resistance, metastasis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.707608/full; https://doaj.org/toc/2234-943X

    URL الوصول: https://doaj.org/article/aeb1047354834ddf994037f3cb4d469e

    View record in DOAJ Full Text Finder

    أضف إلى المفضلة
  3. 3
    Academic Journal
    Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCε/PKCε Signaling Pathway

    المؤلفون: Jiayu Liu, Yongbo Zheng, Yingying Gao, Zhen Quan, Bo Qiao, Luo Li, Ting Li, Limei Duan, Jinxiao Yang, Chunli Luo, Xiaohou Wu

    المصدر: Frontiers in Oncology, Vol 10 (2020)

    مصطلحات موضوعية: KRAS mutation G12C, inhibitor 9, castration-resistant prostate cancer, drug resistance, metastasis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://www.frontiersin.org/article/10.3389/fonc.2020.00075/full; https://doaj.org/toc/2234-943X

    URL الوصول: https://doaj.org/article/313f7147e29c42a2bea8decd07d9c3c0

    View record in DOAJ Full Text Finder

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء